Third, individual variation is substantial: patients with severe insulin resistance or significant mitochondrial dysfunction may respond at lower doses than metabolically healthy athletes
In general, medical weight loss may not be suitable for those who are pregnant, breastfeeding, or planning to become pregnant, or for individuals with a history of certain thyroid conditions (such as medullary thyroid cancer or MEN 2), pancreatitis, or significant kidney or liver disease
Though to our knowledge there are no studies on interactions between GLP-1 and CB1 receptors in the habenula, VTA or other brain regions, there is evidence of reciprocal functional interactions between these two receptors peripherally [57]
scale bars: 3 mm)
Oceans Weight Loss & Med Spa in Fort Lauderdale offers provider-supervised GLP-1 and GLP-1/GIP weight loss options including Semaglutide, Tirzepatide, Wegovy, Ozempic, Mounjaro, Zepbound, and Rybelsus discussions for eligible patients